Biocon Limited (BOM:532523)
India · Delayed Price · Currency is INR 428.25
-3.15 (-0.73%)
At close: May 29, 2026
Biocon Market Cap
Biocon has a market cap or net worth of 693.71 billion as of June 1, 2026. Its market cap has increased by 75.70% in one year.
Market Cap
693.71B
Enterprise Value
835.12B
Revenue
169.27B
Ranking
n/a
PE Ratio
179.91
Stock Price
428.25
Market Cap Chart
Since April 7, 2004, Biocon's market cap has increased from 45.41B to 693.71B, an increase of 1,427.57%. That is a compound annual growth rate of 13.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 693.71B | 31.97% |
| Dec 31, 2025 | 525.64B | 20.22% |
| Dec 31, 2024 | 437.25B | 46.69% |
| Dec 29, 2023 | 298.08B | -4.59% |
| Dec 30, 2022 | 312.41B | -27.97% |
| Dec 31, 2021 | 433.73B | -21.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aarti Drugs | 34.81B |
| Titan Biotech | 18.23B |
| Hester Biosciences | 17.02B |
| CCME Global | 5.29B |
| Zenotech Laboratories | 2.73B |
| Bharat Immunologicals & Biologicals Corporation | 758.24M |
| Transgene Biotek | 238.68M |
| Hindustan Bio Sciences | 87.13M |